No Detail Found!

Intralesional acyclovir in the treatment of cutaneous warts: a novel therapeutic approach

Author(s)
Bhargavi Mayakuntla Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
Suruthi Purushothaman Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
S.S. Ravi Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
B. Indira Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
V. Anitha Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
M. Susmitha Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
V.V.V. Satyanarayana Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
Abstract
Background Warts are the cutaneous manifestations of human papilloma virus infection. Although warts resolve spontaneously, many patients seek treatment as they can be painful and may have psychosocial impact in case of multiple cutaneous warts. Acyclovir is an antiviral medication with established efficacy against DNA viruses, could become a possible revolutionary therapeutic option for warts. Objective The purpose of this therapeutic approach is to determine the effectiveness of intralesional injection of acyclovir in the management of cutaneous warts. Methods A total of 18 patients with warts attending DVL outpatient department were selected for the study. Depending on the size of the lesion, the patients received 0.1ml-0.3ml of intralesional acyclovir diluted with distilled water (70mg/ml) in each lesion. The procedure was repeated every two weeks till complete clearance or upto a total of four sessions. Adverse effects were documented, and the study participants were monitored on a monthly basis for three months following the final injection to look for any relapse. Results All 18 patients completed the study by 8weeks duration. Complete clearance was observed in 9 patients (50%), with an excellent response in 5 patients (27.7%), good response in two patients (11.11%), and no response in 2 patients (11.11%). Conclusion Intralesional acyclovir can be an efficient therapeutic tool for solitary cutaneous warts, but it provides no added benefit for distant warts. It can be beneficial modality in patients seeking for quick response.
Publication Details
Page(s) 495-498
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 33, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Intralesional, Abstract, acyclovir, Novel, eol>Warts
0

Citations

0

Downloads

41

Views